WYMM Tour: Barcelona
22 February 2024, 10:00 - 16:45 CET - Barcelona, Spain
Generate ultra-rich data for answers with impact.
Who says you can’t see it all? With a comprehensive view of structural variants and methylation, nanopore technology powers the bigger and bolder research questions you’ve always wanted to ask.
Join us on Thursday 22nd February 2024 in Barcelona to hear from local experts who are breaking new ground in human genomics, using nanopore technology.
What you're missing matters. Stay on top of what's next.
Aside from talks ranging from human genomics for rare disease, to sequencing for cancer research, the full-day agenda will include networking breaks, Q&A, product displays, and opportunities to engage with your peers and nanopore experts.
Please note that this is an in-person event.
There is no delegate fee for this event, but registration is required. Lunch and refreshments will be provided. Your place at this event will be confirmed via email from events@nanoporetech.com.
Agenda
10:00 – 18:00 hrs CET | Agenda (subject to change) | |
|---|---|---|
10:00 – 10:45 hrs | Registration, breakfast and networking | |
10:45 – 11:10 hrs | What you're missing matters: Catching the unnoticed | Tonya McSherry, Oxford Nanopore Technologies |
11:10 – 11:35 hrs | Bridging the diagnostic gap by long read sequencing | Joris Vermeesch, Laboratory of Cytogenetics and Genome Research |
11:35 – 12:00 hrs | Nanopore-based analysis of cell-free DNA: clinical implications for the management of colorectal cancer | Filippo Martignano, Institute for the Study and Prevention of Cancer (ISPRO) |
12:00 – 13:30 hrs | Lunch | |
13:30 – 13:55 hrs | Oxford Nanopore Technologies bioinformatics update | Dan Fordham, Oxford Nanopore Technologies |
13:55 – 14:20 hrs | Decoding the epitranscriptome and its dynamics at single molecule resolution | Eva Maria Novoa, Center for Genomic Regulation (CRG) |
14:20– 14:45 hrs | Rapid adult’s nephrogenomics | Laurent Mesnard, APHP Sorbonne Université |
14:45 – 15:45 hrs | Networking session | |
15:45 – 16:05 hrs | Panel discussion: The future of nanopore sequencing in clinical research | Moderated by Christophe Fleury, Oxford Nanopore Technologies |
16:05 – 16:35 hrs | Nanopore sequencing of the human mitochondrial and other genomes | Ivo Gut, CNAG |
16:35 – 16:45 hrs | Closing remarks | Oxford Nanopore Technologies |
16:45 – 18:00 hrs | Drinks reception |
Speakers
)
Bridging the diagnostic gap by long read sequencing
Joris Vermeesch, Laboratory of Cytogenetics and Genome Research
The laboratory develops, translates and implements genomic technologies to improve genetic diagnosti...
)
Nanopore-based analysis of cell-free DNA: clinical implications for the management of colorectal cancer
Filippo Martignano, Institute for the Study and Prevention of Cancer (ISPRO)
Filippo started his career as a molecular biologist gaining expertise in translational cancer resear...
)
Decoding the epitranscriptome and its dynamics at single molecule resolution
Eva Maria Novoa, Center for Genomic Regulation (CRG)
Dr. Eva Maria Novoa leads the ‘Epitranscriptomics and RNA Dynamics laboratory’ at the Centre for Gen...
)
Rapid Adult’s Nephrogenomics
Laurent Mesnard, APHP Sorbonne Université
Prof. Laurent Mesnard, is Head of the Intensive Care Nephrology Unit at Assistance Publique Hopitaux...
)
Nanopore Sequencing of the Human Mitochondrial and other Genomes
Ivo Gut, Nanopore Sequencing of the Human Mitochondrial and other Genomes
Since 2010 Director of the Centro Nacional de Analisis Genomico in Barcelona. 1999-2010 Associate Di...